Post challenging serum cytokine profile (Th1 & Th2) in the vaccinated mice (Balb/C) with a new formulation of Leishmania major antigen.

@article{Latifynia2013PostCS,
  title={Post challenging serum cytokine profile (Th1 & Th2) in the vaccinated mice (Balb/C) with a new formulation of Leishmania major antigen.},
  author={A. Latifynia and Ali Khamisipour and M. Gharagozlou and Said Bokaie and M. Vodjgani and Z. Gheflati and Marzieh Mosavi and N. Khansari},
  journal={Turkiye parazitolojii dergisi},
  year={2013},
  volume={37 4},
  pages={
          233-40
        }
}
  • A. Latifynia, Ali Khamisipour, +5 authors N. Khansari
  • Published 2013
  • Biology, Medicine
  • Turkiye parazitolojii dergisi
  • OBJECTIVE The aim of this study was to carry out experiments further to our previous new formulation to modify the Leishmania major antigen that had satisfactory results previously. METHODS In this study we made a preliminary, new vaccine with the same methodology and selected two injection doses (100&200 μg/o.1 mL), three injection Groups: Leishmania plus BCG (LB), Leishmania plus new adjuvant (Teucrium Polium) [LT], Leishmania plus BCG and Teucrium Polium (LBT), and one susceptible mouse… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-6 OF 6 CITATIONS

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 41 REFERENCES

    Evaluation of the effects of a new formulation of Leishmania major antigen in Balb/C and conventional white laboratory mice.

    VIEW 5 EXCERPTS

    The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.

    VIEW 1 EXCERPT

    IL-12 enhances Th1-type responses in human Leishmania donovani infections.

    VIEW 1 EXCERPT